Jeffrey W. Albers - Jun 28, 2022 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Jeffrey W. Albers
Stock symbol
MGTA
Transactions as of
Jun 28, 2022
Transactions value $
$0
Form type
4
Date filed
6/30/2022, 06:34 PM
Previous filing
Jun 16, 2022
Next filing
Aug 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jun 28, 2022 Common Stock 20K $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in full upon the earlier to occur of (a) June 28, 2023 or (b) the next annual meeting of the Issuer's stockholders.

Remarks:

Exhibit 24.1: Power of Attorney